Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded company in the Unknown sector. Across all available filings, 57 corporate insiders have executed 870 transactions totaling $331.6M, demonstrating a bearish sentiment with -$293.2M in net insider flow. The most recent transaction on Feb 18, 2026 involved a transaction of 525,000 shares valued at $0.
VNDA Insider Activity Summary
Who Is Buying VNDA Stock?
No significant insider buying has been recorded for VNDA in the recent period.
Who Is Selling VNDA Stock?
No significant insider selling has been recorded for VNDA in the recent period.
Is Vanda Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VNDA is bearish with an Insider Alignment Score of 6/100 and a net flow of -$293.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
VNDA Frequently Asked Questions
Understanding VNDA Insider Activity
Insider trading at Vanda Pharmaceuticals Inc. (VNDA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 57 insiders are actively trading VNDA stock, having executed 870 transactions in the past 90 days. The most active insider is David Russ Ramsay (Executive), who has made 38 transactions totaling $73.3M.
Related Tools
Track Vanda Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at VNDA file new Form 4 transactions